Resmed (RMD) Invested Capital (2010 - 2026)

Resmed has reported Invested Capital for 17 years, with the latest figure at $6.9 billion in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital rose 11.06% year-over-year to $6.9 billion; the trailing twelve-month figure through Mar 2026 stood at $6.9 billion (up 11.06% YoY), and the FY2025 full-year result was $6.6 billion, up 19.15% from the prior year.
• Invested Capital for Q1 2026 stood at $6.9 billion, up from $6.7 billion in the prior quarter.
• The five-year high for Invested Capital was $6.9 billion in Q1 2026, with the low at $3.9 billion in Q1 2022.
• Historically, Invested Capital has averaged $5.7 billion across 5 years, with a median of $5.6 billion in 2024.
• Annual changes were most pronounced in 2022 — Invested Capital jumped 44.97% — and 2024, when it increased 0.0%.
• Resmed's Invested Capital stood at $5.5 billion in 2022, then increased by 3.07% to $5.7 billion in 2023, then rose by 3.81% to $5.9 billion in 2024, then climbed by 13.67% to $6.7 billion in 2025, then increased by 2.55% to $6.9 billion in 2026.
• The last three Invested Capital figures came in at $6.9 billion (Q1 2026), $6.7 billion (Q4 2025), and $6.5 billion (Q3 2025), per Business Quant data.